Glowing brain with dissolving Alzheimer's plaques representing sitagliptin's neuroprotective effect.

Unlock Your Brain's Potential: How Sitagliptin Could Revolutionize Alzheimer's Treatment

Author's portrait.
Theo Raines in Health & Wellness August 2025 • 4 min read.

"Beyond Diabetes: Exploring the Neuroprotective Power of Sitagliptin in Reducing Neuroinflammation and Fighting Alzheimer's Disease"


The relentless pursuit of effective neuroprotective drugs to combat acute and chronic brain diseases has been ongoing for years. With stroke being the second leading cause of death worldwide, claiming over 6 million lives annually, and Alzheimer's disease contributing to 1.5 million deaths each year, the need for innovative neuroprotective strategies is critical. [Published in Hindawi, BioMed Research International, October 26, 2018]

Emerging research and clinical trials are revealing the neuroprotective potential of DPP-4 inhibitors, with sitagliptin as a prominent example. Primarily used to treat type 2 diabetes by enhancing incretin levels, these drugs are now being investigated for their ability to protect against neuron damage. [Published in Hindawi, BioMed Research International, October 26, 2018]

This article explores the potential mechanisms through which sitagliptin combats neuroinflammation, focusing particularly on its implications for Alzheimer's disease. Understanding these mechanisms could pave the way for new therapeutic interventions, offering hope for those affected by this devastating condition. [Published in Hindawi, BioMed Research International, October 26, 2018]

Sitagliptin's Anti-Inflammatory Action: A Shield for Your Brain

Glowing brain with dissolving Alzheimer's plaques representing sitagliptin's neuroprotective effect.

Inflammation is a key factor in many neuron-damaging diseases. Studies show that the brains and spinal fluid of Alzheimer's patients contain numerous inflammatory substances, including cytokines, chemokines, and reactive oxygen and nitrogen species, which contribute to oxidative damage. [Published in Hindawi, BioMed Research International, October 26, 2018]

Sitagliptin's ability to modulate inflammatory responses is generating interest in its potential to mitigate these harmful processes. By interfering with the NF-kB signaling cascade and reducing excessive protein accumulation, sitagliptin may help to calm the inflammatory storm in the brain. Here’s how it works:

  • Reduces Pro-inflammatory Factors: Sitagliptin decreases levels of TNF-α, IL-6, IL-17, and CD-163, all of which promote inflammation.
  • Enhances Anti-Inflammatory Response: It boosts levels of IL-10 and TGF-β, which help to resolve inflammation and promote healing.
  • Inhibits Harmful Pathways: By suppressing the NF-kB signaling pathway, sitagliptin reduces the activation of genes that drive inflammation.
  • Promotes Microglia Balance: Sitagliptin appears to shift microglia (immune cells in the brain) towards an M2 phenotype, which supports neuroprotection and tissue repair.
Research has demonstrated that sitagliptin reduces markers of neutrophil influx and inflammatory markers like TNF-a and IL-6 in the hippocampus of rats. Premedication with sitagliptin also increases levels of IL-10, known for its anti-inflammatory properties. These findings suggest a consistent pattern of sitagliptin's ability to modulate the immune response in the brain. [Published in Hindawi, BioMed Research International, October 26, 2018]

The Future of Sitagliptin in Neuroprotection

The evidence presented suggests that sitagliptin holds promise as a therapeutic agent for conditions beyond type 2 diabetes. Its anti-inflammatory and neuroprotective properties make it a potential candidate for treating neurodegenerative disorders like Alzheimer's disease and stroke. Further research is needed to fully understand its mechanisms and verify its efficacy in clinical settings, offering hope for new treatments that could significantly improve the lives of those affected. [Published in Hindawi, BioMed Research International, October 26, 2018]

About this Article -

This article was crafted using a human-AI hybrid and collaborative approach. AI assisted our team with initial drafting, research insights, identifying key questions, and image generation. Our human editors guided topic selection, defined the angle, structured the content, ensured factual accuracy and relevance, refined the tone, and conducted thorough editing to deliver helpful, high-quality information.See our About page for more information.

This article is based on research published under:

DOI-LINK: 10.1155/2018/6091014, Alternate LINK

Title: Neuroprotective Activity Of Sitagliptin Via Reduction Of Neuroinflammation Beyond The Incretin Effect: Focus On Alzheimer’S Disease

Subject: General Immunology and Microbiology

Journal: BioMed Research International

Publisher: Hindawi Limited

Authors: Michał Wiciński, Eryk Wódkiewicz, Maciej Słupski, Maciej Walczak, Maciej Socha, Bartosz Malinowski, Katarzyna Pawlak-Osińska

Published: 2018-08-16

Everything You Need To Know

1

What is Sitagliptin and what is it's primary use?

Sitagliptin is primarily used to treat type 2 diabetes by enhancing incretin levels. Emerging research is exploring its potential to protect against neuron damage, particularly in the context of neurodegenerative diseases like Alzheimer's. This involves its anti-inflammatory actions within the brain.

2

How does Sitagliptin reduce inflammation in the brain?

Sitagliptin reduces pro-inflammatory factors like TNF-α, IL-6, IL-17, and CD-163, all of which contribute to inflammation. It also enhances anti-inflammatory responses by boosting levels of IL-10 and TGF-β, which help resolve inflammation and promote healing. Furthermore, it inhibits the NF-kB signaling pathway, reducing the activation of genes that drive inflammation, and promotes a shift in microglia towards an M2 phenotype, supporting neuroprotection and tissue repair.

3

What does neuroinflammation involve, and how can Sitagliptin potentially help?

Neuroinflammation involves the presence of inflammatory substances in the brain, such as cytokines, chemokines, and reactive oxygen and nitrogen species, leading to oxidative damage. Sitagliptin's ability to modulate inflammatory responses may mitigate these harmful processes by interfering with the NF-kB signaling cascade and reducing excessive protein accumulation.

4

What are microglia, and how does Sitagliptin affect them?

Microglia are immune cells in the brain. Research suggests that sitagliptin shifts microglia towards an M2 phenotype. This shift is important because the M2 phenotype supports neuroprotection and tissue repair, helping to counteract the damaging effects of neuroinflammation.

5

What makes Sitagliptin a promising candidate for treating neurodegenerative diseases like Alzheimer's?

Sitagliptin shows promise due to its anti-inflammatory and neuroprotective properties. It is being investigated as a potential therapeutic agent for neurodegenerative disorders like Alzheimer's disease and stroke. Further research is needed to fully understand its mechanisms and confirm its efficacy in clinical settings, which could lead to new treatments that significantly improve the lives of those affected by these conditions. Other DPP-4 inhibitors might show similar potential, but more research is needed to confirm this.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.